Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology study
Yujia Liang, Rui Zhou, Xiaoliu Liang, et al.
European Journal of Pharmacology (2020) Vol. 881, pp. 173227-173227
Closed Access | Times Cited: 23

Showing 23 citing articles:

Targeting NQO1/GPX4-mediated ferroptosis by plumbagin suppresses in vitro and in vivo glioma growth
Sheng Zhan, Li Lü, Shu-shan Pan, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 2, pp. 364-376
Open Access | Times Cited: 71
Network Pharmacology and bioinformatics analyses identify intersection genes of niacin and COVID-19 as potential therapeutic targets
Rong Li, Yu Li, Liang Xiao, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 1279-1290
Open Access | Times Cited: 120
Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19
Rong Li, Ka Wu, Yu Li, et al.
Aging (2020) Vol. 12, Iss. 15, pp. 15784-15796
Open Access | Times Cited: 88
Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer
Shulan Han, Shengnan Bi, Tingting Guo, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 250-263
Closed Access | Times Cited: 61
Anti–coronavirus disease 2019 (COVID‐19) targets and mechanisms of puerarin
Xingyue Qin, Chen Huang, Ka Wu, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 25, Iss. 2, pp. 677-685
Open Access | Times Cited: 47
Prominent Naturally Derived Oxidative-Stress-Targeting Drugs and Their Applications in Cancer Treatment
Eunsun Lee, Dongki Yang, Jeong Hee Hong
Antioxidants (2025) Vol. 14, Iss. 1, pp. 49-49
Open Access
Luteolin Potentially Treating Prostate Cancer and COVID-19 Analyzed by the Bioinformatics Approach: Clinical Findings and Drug Targets
Ye Yu, Ziyan Huang, Manying Chen, et al.
Frontiers in Endocrinology (2022) Vol. 12
Open Access | Times Cited: 17
Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC
Wenyu Wu, Xin Jiao, Wen-xin Song, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Therapeutic targets and molecular mechanism of calycosin for the treatment of cerebral ischemia/reperfusion injury
Songzuo Yu, Ka Wu, Yujia Liang, et al.
Aging (2021) Vol. 13, Iss. 12, pp. 16804-16815
Open Access | Times Cited: 21
Pharmacological Features and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A Narrative Review
Bhoomika Sharma, Chitra Dhiman, Gulam Mustafa Hasan, et al.
Nutrients (2024) Vol. 16, Iss. 17, pp. 3033-3033
Open Access | Times Cited: 2
Bioinformatic and biochemical studies of formononetin against liver injure
Liejun Liao, Huang Li-xiu, Xiang Wei, et al.
Life Sciences (2021) Vol. 272, pp. 119229-119229
Closed Access | Times Cited: 12
Exploring anti-liver cancer targets and mechanisms of oxyresveratrol: in silico and verified findings
Feilan Zhao, Jingru Qin, Yujia Liang, et al.
Bioengineered (2021) Vol. 12, Iss. 2, pp. 9939-9948
Open Access | Times Cited: 12
Medical Significance of Uterine Corpus Endometrial Carcinoma Patients Infected With SARS-CoV-2 and Pharmacological Characteristics of Plumbagin
Yongming Li, Songzuo Yu, Yu Li, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 12
Bioinformatics and experimental findings reveal the therapeutic actions and targets of pachymic acid against cystitis glandularis
Zihao Feng, Hailin Shi, Bojian Liang, et al.
BioFactors (2021) Vol. 47, Iss. 4, pp. 665-673
Closed Access | Times Cited: 10
Uncovering antiobesity-related hypertension targets and mechanisms of metformin, an antidiabetic medication
Yang Lu, Jianxin Yang, Liang Xiao, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 4757-4767
Open Access | Times Cited: 10
Identification and vitro verification of the potential drug targets of active ingredients of Chonglou in the treatment of lung adenocarcinoma based on EMT-related genes
Fulai Zhao, Peng Zhao, Junli Chang, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 3
Upregulation of miR-22-3p contributes to plumbagin-mediated inhibition of Wnt signaling in human colorectal cancer cells
Poonam Yadav, Priyanshu Sharma, Neha Chetlangia, et al.
Chemico-Biological Interactions (2022) Vol. 368, pp. 110224-110224
Closed Access | Times Cited: 5
Clinical characterization and therapeutic targets of vitamin A in patients with hepatocholangiocarcinoma and coronavirus disease
Liang Xiao, Rui Zhou, Yu Li, et al.
Aging (2021) Vol. 13, Iss. 12, pp. 15785-15800
Open Access | Times Cited: 7
In-silico analysis reveals the core targets and mechanisms of CA028, a new derivative of calycosin, in the treatment of colorectal cancer
Feiying Yin, Xing Zhang, Li Yu, et al.
Intelligent Medicine (2022) Vol. 2, Iss. 3, pp. 127-133
Open Access | Times Cited: 2
In Silico Analysis Identifies the Anti‐Liver Injury Targets of Diammonium Glycyrrhizinate: Validated in Perfluorooctanoic Acid‐Lesioned Mouse Model
Jingru Qin, Jianhua Song, Yujia Liang, et al.
Chemistry & Biodiversity (2022) Vol. 19, Iss. 8
Closed Access | Times Cited: 1
Bioinformatic Characteristics and Therapeutic Mechanisms of Calycosin-Anti-Bisphenol A-related Osteosarcoma
Jiachang Tan, Zhenjie Wu, Jun Chen, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Protective effect of vitamin E against plumbagin-induced liver injury and oxidative stress: biochemical, redox, and mitochondrial permeability changes
Olubukola T. Oyebode, Isaac J. Bello, Hammed O. Faleke, et al.
Comparative Clinical Pathology (2023)
Closed Access
Anti-novel coronavirus pneumonia biotarget and mechanism of puerarin
Rong Li, Xingyue Qin, Yu Li, et al.
Authorea (Authorea) (2020)
Open Access
Page 1

Scroll to top